Archives of Gynecology and Obstetrics

, Volume 241, Issue 4, pp 235–247 | Cite as

Altered expression of filaggrin in human papillomavirus (HPV) lesions of the uterine cervix

  • M. Cintorino
  • S. Syrjänen
  • P. Leoncini
  • E. Bellizzi De Marco
  • R. Petracca
  • V. Pallini
  • P. Tosi
  • R. Mäntyjärvi
  • K. Syrjänen


A series of 64 punch biopsies collected from women prospectively followed-up for cervical Human papillomavirus (HPV) infections (with and without CIN), and 38 control biopsies (normal epithelia, and classical CIN) were analysed for expression of filaggrin (a histidine-rich protein constituent of keratohyalin granules) using the ABC technique and polyclonal antibody. HPV typing was completed using the in situ hybridization technique with DNA probes for HPV 6, 11, 16, 18 and 31. Three patterns of filaggrin distribution were differentiated: pattern I, all layers above the basal cells stained irregularly, and pattern III, scattered superficial cells stained positive. There was a significant difference between HPV-noCIN and HPV-CIN lesions in their filaggrin patterns, pattern I being present in the majority (77.7%) of HPV-noCIN lesions, as contrasted to HPV-CIN lesions, where pattern III was the predominant one (43.5%), followed by pattern II (32.6%). In HPV-CIN CIN as well as in CIN lesions, pattern I was inversely related to the grade of CIN, being entirely absent in HPV-CIN III and CIN III. A significant difference exists between CIN and HPV-CIN lesions, concerning the presence of pattern III (4.3% and 43.5%, respectively,P< 0.001). The difference was less dramatic with regard to pattern I (30.4% and 21.7%, respectively,P< 0.05). In the lesions containing HPV 6, 11 or 31 DNA, filaggrin distribution was shown to be more close to that of the normal epithelium (I 36.7%, and II 34.7%), while in the HPV 16 and 18-infected cases, pattern III was the predominant one (46.7%). The assessment of filaggrin pattern in HPV lesions might be of help in evaluating the severity of the disturbance of keratinocyte differentiation induced by the progression of HPV infections.

Key words

Filaggrin expression Cervical HPV infections in situ DNA hybridization Cervical carcinogenesis Keratinocyte differentiation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ball RD, Walker GK, Bernstein IA (1978) Histidine-rich proteins as molecular markers of epidermal differentiation. B Biol Chem 253:5861–5868Google Scholar
  2. 2.
    Burk RD, Kadish AS, Calderin S, Romney SL (1986) Human papillomavirus infection of the cervix detected by cervigovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 154:982–989PubMedGoogle Scholar
  3. 3.
    Burnett TS, Gallimore PH (1983) Establishment of a human keratinocyte cell line carrying complete Human papillomavirus type 1 genome: lack of vegetative viral DNA synthesis upon keratinization. J Gen Virol 64:1509–1520PubMedGoogle Scholar
  4. 4.
    Bychkov V, Chejfec G (1984) Immunocytochemical localization of keratin in normal, dysplastic and neoplastic cervical epithelium. Gynecol Obstet Invest 18:1–5PubMedGoogle Scholar
  5. 5.
    Dale BA (1977) Purification and characterization of a basic protein from the stratum corneum of mammalian epidermis. Biochem Biophys Acta 491:193–204PubMedGoogle Scholar
  6. 6.
    Dale BA, Sun T-T (1983) Filaggrin, 56.5 Kd and 65–67 Kd keratin share an antigen determinant as defined by AE2 monoclonal antibody. J Cell Biol 97:228a-234aGoogle Scholar
  7. 7.
    Dale BA, Resing KA, Lonsdale-Eccles JD (1985) Filaggrin: a keratin filament associated protein. Ann NY Acad Sci 455:330–342PubMedGoogle Scholar
  8. 8.
    de Villiers E-M, Schneider A, Gross G, zur Hausen H (1986) Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol 174:281–286PubMedGoogle Scholar
  9. 9.
    Di Luca D, Pilotti S, Stefanon B, Rotola A, Monini P, Tognon M, de Palo G, Rilke F, Cassai E (1986) Human papillomavirus type 16 DNA in genital tumours pathological and molecular analysis. J Gen Virol 67:583–589PubMedGoogle Scholar
  10. 10.
    Dürst M, Gissmann L, Ikenberg H, zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812–3814PubMedGoogle Scholar
  11. 11.
    Fleckman P, Dale BA, Holbrook KA (1985) Profilaggrin, a high molecular weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol 85:507–512PubMedGoogle Scholar
  12. 12.
    Franke WW, Schiller DL, Moll R, Winter S, Schmid E, Engelbrecht I, Denk H, Krepler R, Platzer B (1981) Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J Mol Biol 153:933–959PubMedGoogle Scholar
  13. 13.
    Franke WW, Moll R, Achtstaetter T, Kuhn C (1986) Cell typing of epithelial and carcinomas of the female genital tract using cytoskeletal proteins as markers. In: Petro R, zur Hausen H (eds) Viral etiology of cervical cancer. Banbury Rep, vol 21. Cold Spring Harbor Laboratory, p 121–148Google Scholar
  14. 14.
    Georges E, Breitburd F, Jibard N, Orth G (1985) Two Shope papillomavirus-associated VX2 carcinoma cell lines with different levels of keratinocyte differentiation and transplantability. J Virol 55:246–250PubMedGoogle Scholar
  15. 15.
    Gissmann L (1984) Papillomaviruses and their associatior with cancer in animals and in man. Cancer Surv 3:161–181Google Scholar
  16. 16.
    Gissmann L (1984) Human papillomavirus DNA in genital tumours. IARC Sci Publ 63:405–411PubMedGoogle Scholar
  17. 17.
    Grubb GS (1986) Human papillomavirus and cervical neoplasia: epidemiological considerations. Int J Epidemiol 15:1–7PubMedGoogle Scholar
  18. 18.
    Gupta J, Gendelman HE, Naghasfar Z, Gupta P, Rosenbein N, Sawada E, Woodruff JD, Shap K (1985) Specific identification of human papillomavirus type in cervical smears and paraffin sections by in situ hybridization with radioactive probes: a preliminary communication. Int J Gynec Pathol 4:211–218Google Scholar
  19. 19.
    Harding CR, Scott IR (1983) Histidine-rich proteins (flaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol 170:651–673PubMedGoogle Scholar
  20. 20.
    Kvedar JC, Fewkes MD, Baden HP (1986) Immunologic detection of markers of keratinocyte differentiation. Its use in neoplastic and preneoplastic lesions of skin. Arch Path Lab Med 110:183–188PubMedGoogle Scholar
  21. 21.
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685PubMedGoogle Scholar
  22. 22.
    Ludwig ME, Lowell DM, Livolsi VA (1981) Cervical condylomatous atypia and its relationship to cervical neoplasia. Am J Clin Pathol 76:255–262PubMedGoogle Scholar
  23. 23.
    McCance DJ, Campion MJ, Clarkson PK, Chester PM, Jenkins D, Singer A (1985) Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol 92:1101–1105PubMedGoogle Scholar
  24. 24.
    Meisels A, Morin C (1981) Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol 12:111–123Google Scholar
  25. 25.
    Moll R, Franke WW, Schiller DL, Geiger B, Krepler K (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24PubMedGoogle Scholar
  26. 26.
    Morris HB, Gatter KC, Pulford K, Haynes P, Charnock M, Taylor-Papadimitriou J, Lane EB, Mason DY (1983) Cervical wart virus infection, intraepithelial neoplasis and carcinoma; an immunohistological study using a panel of monoclonal antibodies. Br J Obstet Gynaecol 90:1069–1081PubMedGoogle Scholar
  27. 27.
    O'Farrell PZ, Goodman HM, O'Farrell PH (1977) High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 12:1133–1142PubMedGoogle Scholar
  28. 28.
    Pfister H (1984) Biology and biochemistry of papillomavirus. Rev Physiol Biochem Pharmacol 99:112–181Google Scholar
  29. 29.
    Pilotti S, Rilke F, De Palo G, Della Torre G, Alasio L (1981) Condylomata of the uterine cervix and koilocytosis of cervical intraepithelial neoplasia. J Clin Pathol 34:532–541PubMedGoogle Scholar
  30. 30.
    Said JW, Sassoon AF, Shintaku IP, Banks-Schlegel S (1984) Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study. J Invest Dermatol 82:449–452PubMedGoogle Scholar
  31. 31.
    Sassoon AF, Said JW, Nash G, Shintaku IP, Banks-Schlegel S (1985) Involucrin in intraepithelial and invasive squamous cell carcinomas of the cervix: an immunohistochemical study. Hum Pathol 16:467–470PubMedGoogle Scholar
  32. 32.
    Singer A, Wilters J, Walker P, Jenkins D, Slavin G, Cowdell H, To A, Husain C (1985) Comparison of prevalence of human papillomavirus antigen in biopsies from women with cervical intraepithelial neoplasia. J Clin Pathol 38:855–857PubMedGoogle Scholar
  33. 33.
    Smith KT, Campo MS (1985) Papillomaviruses and their involvement in oncogenesis. Biomed Pharmacother 39:405–414PubMedGoogle Scholar
  34. 34.
    Steinert PM, Cantieri JS, Teller DC, Lonsdale-Eccles JD, Dale BA (1981) Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci USA 78:4097–4101PubMedGoogle Scholar
  35. 35.
    Sun T-T, Eichner R, Nelson WG, Scheffer BA, Tseng CG, Weiss RA, Järvinen M, Woodcock-Mitchell J (1983) Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 81:109–115Google Scholar
  36. 36.
    Sybert VP, Dale BA, Holbrook KA (1985) Ichtyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 84:191–194PubMedGoogle Scholar
  37. 37.
    Syrjänen KJ (1984) Current concepts on Human papillomavirus (HPV) infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma. Obstet Gynecol Surv 39:252–265PubMedGoogle Scholar
  38. 38.
    Syrjänen K, de Villiers E-M, Väyrynen M, Mäntyjärvi R, Parkkinen S, Saarikoski S, Castren O (1985) Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet I:510–511Google Scholar
  39. 39.
    Syrjänen K, Parkkinen S, Mäntyjärvi R, Väyrynen M, Syrjännen S, Holopainen H, Saarikoski S, Castren O (1985) Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. Eur J Epidermiol 1:180–187Google Scholar
  40. 40.
    Syrjänen K, Mäntyjärvi R, Väyrynen M, Holopainen H, Saarikoski S, Syrjänen S, Parkkinen S, Castren O (1985) Structural protein expression in biological behavior of Human papillomavirus infection in uterine cervix. Cervix & lower female genital tract 3:249–266Google Scholar
  41. 41.
    Syrjänen K, Väyrynen M, Mäntyjärvi R, Parkkinen S, Saarikoski S, Syrjänen S, Castre O (1985) Natural history of HPV infections in uterine cervix as determined by prospective followup. In: Howley PM, Broker TR (eds) Papilloma viruses: molecular and clinical Aspects. UCLA symposia on Molecular and Cellular Biology, vol 32, Alan R Liss, New York, pp 31–45Google Scholar
  42. 42.
    Syrjänen KJ (1986) Human papillomavirus (HPV) infections of the female genital tract and their associations with intracepithelial neoplasia and squamous cell carcinoma. Pathol Annu 21:53–89PubMedGoogle Scholar
  43. 43.
    Syrjänen K, Mäntyjärvi R, Parkkinen S, Väyrynen M, Saarikoski S, Syrjänen S, Casten O (1986) Prospective follow-up in assessment of the biological behaviour of cervical HPV-associated dysplastic lesions. In: Peto R, zur Hausen H (eds) Viral Etiology of Cervical Cancer. Banbury Rep, vol 21. Cold Spring Harbor Laboratory, pp 167–177Google Scholar
  44. 44.
    Syrjänen S, Syrjänen K, Mäntyjärvi R, Parkkinen S, Väyrynen M, Saarikoski S, Castren O (1986) Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol 239:39–48PubMedGoogle Scholar
  45. 45.
    Syrjänen S, Syrjänen K (1986) An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. J Virol Methods 14:293–304PubMedGoogle Scholar
  46. 46.
    Syrjänen S, Cintorino M, Armellini D, Del Vecchio MT, Leoncini P, Bugnoli M, Pallini V, Silvestri S, Tosi P, Mäntyjärvi R, Syrjänen K (1987) Expression of cytokeratin polypeptides in human papillomavirus (HPV) lessions of the uterine cervix. I. Relationships to grade of CIN and HPV type. Int J Gynecol Pathol (in press)Google Scholar
  47. 47.
    Taichman LB, Reilly SS, La Porta RF (1983) The role of keratinocyte differentiation in the expression of epitheliotropic viruses. J Invest Dermatol, 81:137–140Google Scholar
  48. 48.
    Taichman LB, Breitburd F, Croissant O, Orth G (1984) The search for a culture system for papillomaviruses. J Invest Dermatol 83:2–6Google Scholar
  49. 49.
    Tomita Y, Kubota K, Kasai T, Sekiya S, Takamizawa H, Simizu B (1986) Detection of Human papillomavirus DNA in genital warts, cervical dysplasias and neoplasias. Intervirology 25:151–157PubMedGoogle Scholar
  50. 50.
    Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354PubMedGoogle Scholar
  51. 51.
    Warhol MJ, Pinkus GS, Rice RH, El-Tawil GH, Lancaster WD, Jenson AB, Kurman RJ (1984) Papillomavirus infection of the cervix. III. Relationship of the presence of viral structural proteins to the expression of involucrin. Int J Gynecol Pathol 3:71–81PubMedGoogle Scholar
  52. 52.
    Woodruff JD, Braun L, Cavalieri R, Gupta P, Pass F, Shah KV (1980) Immunologic identification of papillomavirus antigen in condyloma tissues from the female genital tract. Obstet Gynecol 56:727–732PubMedGoogle Scholar
  53. 53.
    zur Hausen H (1977) Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78:1–30PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • M. Cintorino
    • 1
  • S. Syrjänen
    • 3
  • P. Leoncini
    • 2
  • E. Bellizzi De Marco
    • 2
  • R. Petracca
    • 3
  • V. Pallini
    • 2
  • P. Tosi
    • 1
  • R. Mäntyjärvi
    • 4
  • K. Syrjänen
    • 5
    • 6
  1. 1.Institute of Pathological Anatomy and HistologyUniversity of SienaSienaItaly
  2. 2.SCLAVO Research CenterSienaItaly
  3. 3.Department of Oral PathologyUniversity of KuopioKuopioFinland
  4. 4.Department of Clinical MicrobiologyUniversity of KuopioKuopioFinland
  5. 5.Department of PathologyUniversity of KuopioKuopioFinland
  6. 6.Laboratory of Pathology and Cancer ResearchFinnish Cancer SocietyKuopioFinland

Personalised recommendations